News
-
-
COMMUNIQUÉ DE PRESSE
Curiteva Announces David Schmidt as Chief Commercial Officer
Curiteva appoints David Schmidt as Chief Commercial Officer, bringing over 20 years of expertise in commercial strategy and success in the medical device marketplace. Schmidt to drive innovative technology in patient care -
COMMUNIQUÉ DE PRESSE
Renowned Neurosurgeon Dr. Kevin Foley Appointed to Curiteva’s Board of Directors
Curiteva appoints Dr. Kevin Foley, MD, a distinguished neurosurgeon and inventor, to its board of directors. Dr. Foley will bring significant clinical insights to the company's cutting-edge technology and groundbreaking Inspire 3D Printed Trabecular PEEK implant -
COMMUNIQUÉ DE PRESSE
Inspire(R) 3D Printed Trabecular PEEK(TM) With HAFUSE(R) Lumbar Interbody System Cleared by FDA
Curiteva, a technology manufacturer based in Huntsville, AL, has announced FDA 510(k) clearance for their Inspire 3D Printed Trabecular PEEK Lumbar Interbody Fusion System, marking their second FDA cleared 3D printed PEEK implant. The proprietary printing operation and rigorous quality and process controls demonstrate the company's commitment to operational efficiency. The groundbreaking additive process produces a fully interconnected trabecular PEEK lattice structure to promote osseointegration and superior biomechanics. The company's commitment to lean operational efficiency has resulted in over 7,000 implants now commercially available in inventory. Curiteva plans to publish patient outcomes for Inspire cervical implant later this year, reinforcing their pre-clinical observations. For more information, visit www.curiteva.com.
